ES2080314T3 - Composiciones farmaceuticas. - Google Patents

Composiciones farmaceuticas.

Info

Publication number
ES2080314T3
ES2080314T3 ES91908384T ES91908384T ES2080314T3 ES 2080314 T3 ES2080314 T3 ES 2080314T3 ES 91908384 T ES91908384 T ES 91908384T ES 91908384 T ES91908384 T ES 91908384T ES 2080314 T3 ES2080314 T3 ES 2080314T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
medicaments
wafer
delivery
sub
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91908384T
Other languages
English (en)
Inventor
Geoffrey David Tovey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline & French Laboratories Ltd
Original Assignee
Smith Kline & French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline & French Laboratories Ltd filed Critical Smith Kline & French Laboratories Ltd
Application granted granted Critical
Publication of ES2080314T3 publication Critical patent/ES2080314T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE DESCRIBEN COMPOSICIONES FARMACEUTICAS EN FORMA DE PASTILLA PARA EL SUMINISTRO DE MEDICAMENTOS A LA MUCOSA SUBLINGUAL.
ES91908384T 1990-04-26 1991-04-24 Composiciones farmaceuticas. Expired - Lifetime ES2080314T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909009390A GB9009390D0 (en) 1990-04-26 1990-04-26 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES2080314T3 true ES2080314T3 (es) 1996-02-01

Family

ID=10675032

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91908384T Expired - Lifetime ES2080314T3 (es) 1990-04-26 1991-04-24 Composiciones farmaceuticas.

Country Status (15)

Country Link
EP (1) EP0526524B1 (es)
JP (1) JPH05506655A (es)
AT (1) ATE131383T1 (es)
AU (1) AU649041B2 (es)
CA (1) CA2081109A1 (es)
DE (1) DE69115476T2 (es)
DK (1) DK0526524T3 (es)
ES (1) ES2080314T3 (es)
GB (1) GB9009390D0 (es)
GR (1) GR3019298T3 (es)
IE (1) IE911381A1 (es)
NZ (1) NZ237930A (es)
PT (1) PT97476B (es)
WO (1) WO1991016041A1 (es)
ZA (1) ZA913072B (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1134163A (zh) * 1993-08-19 1996-10-23 辛勒斯治疗系统公司 水溶性压敏粘膜粘合剂和配备该粘合剂用于放置在有粘膜衬里的体腔内的器具
DE69531992T2 (de) * 1994-08-04 2004-07-22 Elan Drug Delivery Ltd., Ruddington Feste verabreichungssysteme zur gesteuerten freisetzung von darin eingebauten molekülen sowie verfahren zu deren herstellung
PT824344E (pt) 1995-05-09 2005-09-30 Phoqus Pharmaceuticals Ltd Composicao de revestimento em po para revestimento electrostatico de substratos farmaceuticos
US7008668B2 (en) 1995-05-09 2006-03-07 Phoqus Pharmaceuticals Limited Powder coating composition for electrostatic coating of pharmaceutical substrates
DE19646392A1 (de) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
GB9623634D0 (en) 1996-11-13 1997-01-08 Bpsi Holdings Inc Method and apparatus for the coating of substrates for pharmaceutical use
AU3869399A (en) * 1998-04-27 1999-11-16 Elan Pharmaceuticals, Inc. Transdermal administration of fenoldopam
ES2219037T3 (es) * 1998-07-24 2004-11-16 Alza Corporation Formulaciones para la administracion transdermica de fenoldopam.
US6699497B1 (en) 1998-07-24 2004-03-02 Alza Corporation Formulations for the transdermal administration of fenoldopam
WO2000054794A1 (en) * 1999-03-18 2000-09-21 Yng Wong Quing Non Wafer delivery system
US6583160B2 (en) * 1999-04-14 2003-06-24 Steve Smith Nicotine therapy method and oral carrier for assuaging tobacco-addiction
EP1196137B1 (en) 1999-07-02 2004-12-22 The Procter & Gamble Company Systems comprising organosiloxane resins for delivering oral care substances and for prolonging such delivery
GB0002305D0 (en) 2000-02-01 2000-03-22 Phoqus Limited Power material for electrostatic application
IT1318618B1 (it) * 2000-07-10 2003-08-27 A C R Applied Coating Res S A Microsfere bioadesive a rilascio rapido per la somministrazionesublinguale di principi attivi.
US8524200B2 (en) 2002-09-11 2013-09-03 The Procter & Gamble Company Tooth whitening products
CN104397869B (zh) 2003-11-07 2016-06-08 美国无烟烟草有限责任公司 烟草组合物
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
GB0407312D0 (en) 2004-03-31 2004-05-05 Phoqus Pharmaceuticals Ltd Method and apparatus for the application of powder material to substrates
US20100312333A1 (en) 2009-04-29 2010-12-09 The Cleveland Clinic Foundation Apparatus and method for replacing a diseased cardiac valve
DE102008014533A1 (de) * 2008-03-15 2009-09-17 Lts Lohmann Therapie-Systeme Ag Gingival-Wafer
US20090276040A1 (en) 2008-05-01 2009-11-05 Edwards Lifesciences Corporation Device and method for replacing mitral valve
AU2009317876B2 (en) 2008-11-21 2014-01-16 Percutaneous Cardiovascular Solutions Pty Limited Heart valve prosthesis and method
AU2010236288A1 (en) 2009-04-15 2011-10-20 Cardiaq Valve Technologies, Inc. Vascular implant and delivery system
US8449599B2 (en) 2009-12-04 2013-05-28 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
EP3459500B1 (en) 2010-09-23 2020-09-16 Edwards Lifesciences CardiAQ LLC Replacement heart valves and delivery devices
US12502276B2 (en) 2011-05-16 2025-12-23 Edwards Lifesciences Corporation Inversion delivery device and method for a prosthesis
MX361101B (es) 2012-10-17 2018-11-27 Procter & Gamble Tira para el suministro de un activo para el cuidado bucal y métodos para aplicar activos para el cuidado bucal.
US9439763B2 (en) 2013-02-04 2016-09-13 Edwards Lifesciences Corporation Prosthetic valve for replacing mitral valve
US20140277427A1 (en) 2013-03-14 2014-09-18 Cardiaq Valve Technologies, Inc. Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US9532870B2 (en) 2014-06-06 2017-01-03 Edwards Lifesciences Corporation Prosthetic valve for replacing a mitral valve
CA2962747C (en) 2014-09-28 2023-02-28 Cardiokinetix, Inc. Apparatuses for treating cardiac dysfunction
ES2989081T3 (es) 2014-11-26 2024-11-25 Edwards Lifesciences Corp Válvula cardíaca protésica transcatéter y sistema de suministro
EP3271000B1 (en) 2015-03-20 2020-06-17 Cardiokinetix, Inc. Systems for delivering an implantable device
US10441416B2 (en) 2015-04-21 2019-10-15 Edwards Lifesciences Corporation Percutaneous mitral valve replacement device
US10350062B2 (en) 2016-07-21 2019-07-16 Edwards Lifesciences Corporation Replacement heart valve prosthesis
EP4454613A3 (en) 2016-08-26 2025-01-29 Edwards Lifesciences Corporation Multi-portion replacement heart valve prosthesis
ES2923913T3 (es) 2017-07-06 2022-10-03 Edwards Lifesciences Corp Sistema de suministro de carril orientable
WO2019147846A2 (en) 2018-01-25 2019-08-01 Edwards Lifesciences Corporation Delivery system for aided replacement valve recapture and repositioning post- deployment
US12447014B2 (en) 2019-04-12 2025-10-21 Edwards Lifesciences Corporation Valve with multi-part frame and associated resilient bridging features
ES2982566T3 (es) 2019-04-23 2024-10-16 Edwards Lifesciences Corp Sistema de suministro de implantes motorizado
JP2021147362A (ja) * 2020-03-23 2021-09-27 学校法人常翔学園 舌下投与用ゼリー剤
EP4247297A1 (en) 2020-12-18 2023-09-27 Edwards Lifesciences Corporation Storage jar assembly for aprosthetic heart valve
EP4422552A1 (en) 2021-10-27 2024-09-04 Edwards Lifesciences Corporation System and method for crimping and loading a prosthetic heart valve

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE871821C (de) * 1950-10-24 1953-03-26 Curt Angelmi Traeger fuer Arzneimittel oder aehnliche dem Koerper einzuverleibende Stoffe
GB2022999A (en) * 1978-06-17 1979-12-28 Culpitt & Son Ltd G Paper compositions incorporating medicaments
GB2085299A (en) * 1980-10-09 1982-04-28 English Grains Ltd Treating sores using wafer-like carrier with active ingredients
CH653550A5 (de) * 1981-10-20 1986-01-15 Sandoz Ag Pharmazeutische zusammensetzung zur verzoegerten freigabe eines medikamentes im mundbereich.
JPS6185315A (ja) * 1984-10-04 1986-04-30 Teikoku Seiyaku Kk シ−ト状製剤

Also Published As

Publication number Publication date
GR3019298T3 (en) 1996-06-30
WO1991016041A1 (en) 1991-10-31
PT97476B (pt) 1998-08-31
DE69115476T2 (de) 1996-06-05
IE911381A1 (en) 1991-11-06
NZ237930A (en) 1993-08-26
JPH05506655A (ja) 1993-09-30
DE69115476D1 (de) 1996-01-25
DK0526524T3 (da) 1996-01-29
AU649041B2 (en) 1994-05-12
CA2081109A1 (en) 1991-10-27
ZA913072B (en) 1992-11-25
EP0526524A1 (en) 1993-02-10
GB9009390D0 (en) 1990-06-20
ATE131383T1 (de) 1995-12-15
PT97476A (pt) 1992-01-31
AU7748191A (en) 1991-11-11
EP0526524B1 (en) 1995-12-13

Similar Documents

Publication Publication Date Title
DK0526524T3 (da) Farmaceutiske præparater
FI963424A0 (fi) Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi
SE8903042L (sv) Pharmaceutical compositions comprising cyklosporins
MX9101175A (es) Composicion farmaceutica para administracion nasal
DE3863963D1 (de) Pharmazeutische zusammensetzungen.
DE3868986D1 (de) Pharmazeutische zusammensetzungen.
DE69115263D1 (de) Pharmazeutische zusammensetzungen.
FI925661L (fi) Injicerbar farmaceutisk komposition
LV10953A (lv) Aizvietotie benzimidazoli to iegusanas panemiens pielietojums farmaceitiska kompozicija
FI893643A7 (fi) Farmaseuttisia koostumuksia
FI910088A7 (fi) Oraalinen farmaseuttinen koostumus
UA26064A1 (uk) Фармацевтичhа композиція
FR2674755B1 (fr) Nouvelles compositions medicamenteuses immunostimulatrices.
SE8306225L (sv) 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma
FI913639A7 (fi) Farmaceutiska kompositioner.
DK0511991T3 (da) Farmaceutisk formulering
DE3866789D1 (de) Pharmazeutische zusammensetzungen.
DE69123190D1 (de) Hirudin enthaltende orale Arzneimittel
IT8747977A0 (it) Composizioni farmaceutiche
FI910773A0 (fi) Farmaceutisk komposition innehaollande ett episialo-kolhydratkomplex.
DE3768109D1 (de) Pharmazeutische zusammensetzungen.
FI932650A7 (fi) B-solujen maligniteettien hoitoon tarkoitetut farmaseuttiset seokset
IT9048244A0 (it) Composizione farmaceutica ad effetto cicatrizzante.
IT9021264A0 (it) Composizioni farmaceutiche per la somministrazione intranasale di calcitonina
FI903653A7 (fi) Paikallisesti annettava farmaseuttinen koostumus

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 526524

Country of ref document: ES